http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104610393-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_159936a9a847e1b85fb4d921ae15d764 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2015-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bcb4ce2c07706533757f51b0f91eaf8 |
| publicationDate | 2015-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104610393-A |
| titleOfInvention | A class of compounds containing glucosamine and halopyridine structures and uses thereof |
| abstract | The present invention relates to the field of medicine related to type II diabetes. Specifically, the present invention relates to a class of GPR119 agonist containing glucosamine and halopyridine structures, its preparation method and its application in the preparation of type II diabetes drugs. Wherein, X is selected from halogen substituents. |
| priorityDate | 2015-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.